Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
NCT02575430
RET NAT 01
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT.
Type: Observational
Status of the trial: Completed
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 2015-12-01
- Closing Date: 2016-03-01
Criteria
Children: Yes
Adults: Yes
Funder Type: industry
HCP: Principal investigators
- Rigshospitalet, Copenhagen, Denmark
- The Rotterdam Eye Hospital, Rotterdam, Netherlands
- Centre for Ophthalmology, University Eye Hospital, Tübingen, Germany
- Moorfields Eye Hospital NHS Foundation Trust
- Central Manchester University Hospitals NHS Foundation Trust, Manchester AcademicHealth Sciences Centre (MAHSC)
HCP: Other investigators
Within ERN-EYE members
Principal investigators
Other investigators
Workgroups
Retinal Rare Eye Diseases (WG1)
This ERN is supported by:
